Skip to main content
. 2016 Mar 15;9:71–82. doi: 10.2147/DMSO.S65588

Figure 1.

Figure 1

Mechanisms involved in hyperglycemia in T2D and site of action of metformin and dapagliflozin.

Note: Through direct and indirect mechanisms, combination therapy with metformin and dapagliflozin may reduce hyperglycemia via effects on several of these pathways.

Abbreviations: GI, gastrointestinal; GLP-1, glucagon-like peptide-1; T2D, type 2 diabetes.